Pay in 4 interest-free payments of $5183.62 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Fath-Goodin et al
02 Instructions (PDF)
Patent information:VE-BEVS Cell Line United States Patent 7
Sf9-derived VE-CL-03 cell line suitable for the enhanced expression of proteins of unknown toxicity and stability or for general enhancement of most recombinant proteins expressed in conventional recombinant BEVS viruses
VE-BEVS Insect Cell Line 10030 (1x10⁷ cells; frozen) (VE-CL-03) General enhancement of most recombinant proteins Fath-Goodin et alParaTechs Vankyrin Enhanced Baculovirus Expression Vector System or VE BEVS technology enhances protein expression from the BEVS while reducing the cost of labor and materials. Vankyrin Enhanced Insect Cells (VE cells) are transgenic insect Spodoptera frugiperda (Sf9) cells that have been engineered to stably express the Campoletis sonorensis ichnovirus P vank 1 protein (Steele et al., 2017; Fath Goodin et al., 2006; Kroemer and Webb, 2006). Sf9
US$ 144.50
US$ 24.95
US$ 45.00
US$ 114.50
US$ 114.50
US$ 139.50
US$ 29.95
US$ 24.95
US$ 25.20
